• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-氟代脱氧葡萄糖在腹腔神经节摄取:前列腺癌 PET 成像的一个陷阱。

18F-Fluciclovine Uptake in Celiac Ganglia: A Pitfall in Prostate Cancer PET Imaging.

机构信息

From the Department of Radiology, University of Washington, Seattle, WA.

出版信息

Clin Nucl Med. 2019 Sep;44(9):743-745. doi: 10.1097/RLU.0000000000002693.

DOI:10.1097/RLU.0000000000002693
PMID:31283598
Abstract

We present 4 cases of patients who underwent F-fluciclovine PET for prostate cancer demonstrating physiologic uptake in the celiac ganglia, which could be mistaken for metastatic lymphadenopathy if the celiac ganglia have a nodular configuration and uptake higher than bone marrow. Uptake in celiac, cervical, and sacral ganglia has been reported previously as an important pitfall in Ga-PSMA-HBED-CC PET for prostate cancer. In our patients, only celiac ganglion uptake was visualized. Advances in PET scanner technology may cause physiologic uptake of F-fluciclovine in celiac ganglia to become more visually distinguishable from muscular uptake in adjacent diaphragmatic crura.

摘要

我们呈现了 4 例前列腺癌患者行 F-氟代脱氧胸苷 PET 的病例,这些患者的腹腔神经节有生理性摄取,若腹腔神经节呈结节状并有高于骨髓的摄取,则可能被误诊为转移性淋巴结病。此前,镓-PSMA-HBED-CC PET 用于前列腺癌时,已报道腹腔神经节、颈神经节和骶神经节的摄取是一个重要的陷阱。在我们的患者中,仅可见腹腔神经节摄取。PET 扫描仪技术的进步可能会使 F-氟代脱氧胸苷在腹腔神经节中的生理性摄取与相邻膈肌脚的肌肉摄取在视觉上更易区分。

相似文献

1
18F-Fluciclovine Uptake in Celiac Ganglia: A Pitfall in Prostate Cancer PET Imaging.18F-氟代脱氧葡萄糖在腹腔神经节摄取:前列腺癌 PET 成像的一个陷阱。
Clin Nucl Med. 2019 Sep;44(9):743-745. doi: 10.1097/RLU.0000000000002693.
2
Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging.镓-PSMA-HBED-CC 在颈、腹腔神经节和骶神经节的摄取是前列腺癌 PET 成像中的一个重要陷阱。
J Nucl Med. 2018 Sep;59(9):1406-1411. doi: 10.2967/jnumed.117.204677. Epub 2018 Jan 25.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.18F-氟丁氨酸 PET/CT 扫描摄取增加的转移性男性乳腺癌。
Clin Nucl Med. 2018 Jan;43(1):23-24. doi: 10.1097/RLU.0000000000001893.
5
F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.氟[^18^]F-氟代脱氧鸟苷参数与复发性前列腺癌靶向前列腺活检的真阳性相关。 [^18^]: ^18^F-fluoroethyltyrosine (^18^F-FET)
J Nucl Med. 2019 Nov;60(11):1531-1536. doi: 10.2967/jnumed.119.227033. Epub 2019 Apr 6.
6
Uptake of 18F-Fluciclovine in Paget Disease.18F-氟柳氯维在佩吉特病中的摄取。
Clin Nucl Med. 2019 Nov;44(11):e614-e616. doi: 10.1097/RLU.0000000000002670.
7
18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer.18F-氟代脱氧葡萄糖摄取偶然检测到的前列腺癌生化复发患者的肝细胞癌。
Clin Nucl Med. 2018 Sep;43(9):695-696. doi: 10.1097/RLU.0000000000002176.
8
Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.在一名前列腺癌患者行 PET/CT 成像检查时,偶然发现其患有硬纤维瘤,该肿瘤摄取 18F-Fluciclovine。
Clin Nucl Med. 2021 Apr 1;46(4):355-357. doi: 10.1097/RLU.0000000000003459.
9
Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.18F-FDG 和 18F-Fluciclovine 摄取模式在一位患有低分化肺腺癌和前列腺癌生化复发患者中的差异。
Clin Nucl Med. 2020 Jan;45(1):e63-e64. doi: 10.1097/RLU.0000000000002781.
10
Uptake in sympathetic ganglia on Ga-PSMA-HBED PET/CT: A potential pitfall in scan interpretation.镓-PSMA-HBED PET/CT上交感神经节的摄取:扫描解读中的一个潜在陷阱。
J Med Imaging Radiat Oncol. 2017 Dec;61(6):732-738. doi: 10.1111/1754-9485.12622. Epub 2017 Jun 17.